| 1 | [SID26747907] | Active | Potency | 8.9125 | Confirmation Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) [AID489007, Type: confirmatory] | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | Confirmation Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) | | AID | 489007 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] | | PubMed | | | Data Table |  |
|
| 2 | [SID26747907] | Active | Potency | 28.1838 | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2517, Type: confirmatory] | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) | | AID | 2517 | | BioAssay type | confirmatory | | Target | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] | | PubMed | | | Data Table |  |
|
| 3 | [SID26747907] | Active | Potency | 39.8107 | Inhibitors of USP1/UAF1: Pilot qHTS [AID504865, Type: confirmatory] | USP1 protein [Homo sapiens] [gi:118600387] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | Inhibitors of USP1/UAF1: Pilot qHTS | | AID | 504865 | | BioAssay type | confirmatory | | Target | USP1 protein [Homo sapiens] [gi:118600387] | | PubMed | | | Data Table |  |
|
| 4 | [SID26747907] | Active | | | qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) [AID880, Type: confirmatory] | RGS12 [Homo sapiens] [gi:3290016] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) | | AID | 880 | | BioAssay type | confirmatory | | Target | RGS12 [Homo sapiens] [gi:3290016] | | PubMed | | | Data Table |  |
|
| 5 | [SID26747907] | Unspecified | | | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP) [AID1471, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Unspecified | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP) | | AID | 1471 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 6 | [SID26747907] | Unspecified | | | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP) [AID1471, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Unspecified | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP) | | AID | 1471 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 7 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 8 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 9 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 10 | [SID26747907] | Inactive | Potency | | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 11 | [SID26747907] | Inactive | Potency | | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 12 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide [AID1766, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide | | AID | 1766 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 13 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide [AID1768, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide | | AID | 1768 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 14 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF [AID1454, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF | | AID | 1454 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 15 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF [AID1454, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF | | AID | 1454 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 16 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF [AID1454, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF | | AID | 1454 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 17 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 18 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 19 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 20 | [SID26747907] | Inactive | Potency | | Confirmation qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) [AID2390, Type: confirmatory] | RGS12 [Homo sapiens] [gi:3290016] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Confirmation qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) | | AID | 2390 | | BioAssay type | confirmatory | | Target | RGS12 [Homo sapiens] [gi:3290016] | | PubMed | | | Data Table |  |
|
| 21 | [SID26747907] | Inactive | Potency | | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 22 | [SID26747907] | Inactive | Potency | | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 23 | [SID26747907] | Inactive | Potency | | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 24 | [SID26747907] | Inactive | Potency | | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 25 | [SID26747907] | Inactive | Potency | | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 26 | [SID26747907] | Inactive | Potency | | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 27 | [SID26747907] | Inactive | Potency | | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 28 | [SID26747907] | Inactive | Potency | | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 29 | [SID26747907] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature [AID924, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature | | AID | 924 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 30 | [SID26747907] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature [AID924, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature | | AID | 924 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 31 | [SID26747907] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature [AID924, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature | | AID | 924 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 32 | [SID26747907] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature [AID924, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature | | AID | 924 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 33 | [SID26747907] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature [AID902, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature | | AID | 902 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 34 | [SID26747907] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature [AID902, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature | | AID | 902 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 35 | [SID26747907] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature [AID902, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature | | AID | 902 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 36 | [SID26747907] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature [AID902, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature | | AID | 902 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table |  |
|
| 37 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 38 | [SID26747907] | Inactive | Potency | | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region [AID923, Type: confirmatory] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region | | AID | 923 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID26747907] | Inactive | Potency | | Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1463, Type: confirmatory] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1463 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID26747907] | Inactive | Potency | | Quantitative High-Throughput Screen for Regulators of Epigenetic Control [AID1865, Type: confirmatory] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Quantitative High-Throughput Screen for Regulators of Epigenetic Control | | AID | 1865 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID26747907] | Inactive | Potency | | qHTS Assay for Compounds that Induce Erasure of Genomic Imprints [AID1948, Type: confirmatory] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Compounds that Induce Erasure of Genomic Imprints | | AID | 1948 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID26747907] | Inactive | Potency | | Counterscreen for Luciferase (Kinase-Glo TM) Inhibition [AID1379, Type: confirmatory] | luciferase [Photuris pennsylvanica] [gi:1669525] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Counterscreen for Luciferase (Kinase-Glo TM) Inhibition | | AID | 1379 | | BioAssay type | confirmatory | | Target | luciferase [Photuris pennsylvanica] [gi:1669525] | | PubMed | | | Data Table |  |
|
| 43 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 44 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 [AID893, Type: confirmatory] | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 | | AID | 893 | | BioAssay type | confirmatory | | Target | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] | | PubMed | | | Data Table |  |
|
| 45 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore) [AID892, Type: confirmatory] | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore) | | AID | 892 | | BioAssay type | confirmatory | | Target | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] | | PubMed | | | Data Table |  |
|
| 46 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore) [AID875, Type: confirmatory] | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore) | | AID | 875 | | BioAssay type | confirmatory | | Target | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] | | PubMed | | | Data Table |  |
|
| 47 | [SID26747907] | Inactive | Potency | | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS [AID602332, Type: confirmatory] | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS | | AID | 602332 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] | | PubMed | | | Data Table |  |
|
| 48 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 49 | [SID26747907] | Inactive | Potency | | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 50 | [SID26747907] | Inactive | Potency | | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26747907 | | CID | 23713216 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|